Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-13

Clinical Trial Update: A Double Blind, Randomized Placebo Controlled Study of the Efficacy, Safety and of Quetiapine Fumarate (Seroquel®) as Potentiation SSRI's, and SNRI's Treatment in Major Depression With Anxiety [Phase 4]

View source ↗

Summary

This Phase 4 double-blind, randomized, placebo-controlled study evaluated quetiapine fumarate (Seroquel) as augmentation to SSRI/SNRI therapy in adults with maj…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SEROQUEL (QUETIAPINE)

Snippet

Sponsor: Dr Alexander McIntyre Inc. | Conditions: Major Depression With Comorbid Anxiety Symptoms | Phase 4 | Status: COMPLETED